MedTrace Logo

CICERO- A Care Home Study of COVID-19

NCT04453553 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 461

Last updated 2023-08-02

No results posted yet for this study

Summary

The primary objective of the study is to determine whether, at 21 days, care homes that implemented near-patient daily testing have a lower rate of confirmed CoV-2 infections than care homes following the DHSC standard of care testing of symptomatic residents.

Conditions

Interventions

DIAGNOSTIC_TEST

Q16 testing

Nasal swab tested on a rapid near patient device

DIAGNOSTIC_TEST

Nasopharyngeal swab and main laboratory

Standard of care testing

Sponsors & Collaborators

  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • Joanne Martin · Queen Mary University London

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-02
Primary Completion
2020-10-27
Completion
2020-10-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04453553 on ClinicalTrials.gov